Selected research
Industry Growth & Trends
Global Hemostatic Powder Spray Industry Growth and Trends Forecast to 2032
Market perspective
The global Hemostatic Powder Spray market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Hemostatic Powder Spray is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Hemostatic Powder Spray is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Hemostatic Powder Spray is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Hemostatic Powder Spray include Medtronic, QuikClot, Pfizer Inc., Hemostasis, LLC, Ethicon Inc., EndoClot Plus, Inc, CryoLife, Inc., Cook Medical and BD, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Hemostatic Powder Spray market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Hemostatic Powder Spray market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hemostatic Powder Spray market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hemostatic Powder Spray.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Hemostatic Powder Spray market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Hemostatic Powder Spray Market by Company
Medtronic
QuikClot
Pfizer Inc.
Hemostasis, LLC
Ethicon Inc.
EndoClot Plus, Inc
CryoLife, Inc.
Cook Medical
BD
Baxter International Inc.
B. Braun
Advanced Medical Solutions Group
Hemostatic Powder Spray Segment by Type
Less than 50ml
50ml and Above
Hemostatic Powder Spray Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
Hemostatic Powder Spray Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatic Powder Spray market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemostatic Powder Spray and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatic Powder Spray.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemostatic Powder Spray manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Hemostatic Powder Spray in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Less than 50ml
- 50ml and Above
Applications
- Hospital Pharmacy
- Retail Pharmacy
- Others
Companies covered
- Medtronic
- QuikClot
- Pfizer Inc.
- Hemostasis, LLC
- Ethicon Inc.
- EndoClot Plus, Inc
- CryoLife, Inc.
- Cook Medical
- BD
- Baxter International Inc.
- B. Braun
- Advanced Medical Solutions Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Hemostatic Powder Spray Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Hemostatic Powder Spray Sales Estimates and Forecasts (2021-2032)
- 1.3 Hemostatic Powder Spray Market by Type
- 1.3.1 Less than 50ml
- 1.3.2 50ml and Above
- 1.4 Global Hemostatic Powder Spray Market Size by Type
- 1.4.1 Global Hemostatic Powder Spray Market Size Overview by Type (2021-2032)
- 1.4.2 Global Hemostatic Powder Spray Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Hemostatic Powder Spray Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Hemostatic Powder Spray Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Hemostatic Powder Spray Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Hemostatic Powder Spray Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Hemostatic Powder Spray Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Hemostatic Powder Spray Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Hemostatic Powder Spray Industry Trends
- 2.2 Hemostatic Powder Spray Industry Drivers
- 2.3 Hemostatic Powder Spray Industry Opportunities and Challenges
- 2.4 Hemostatic Powder Spray Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Hemostatic Powder Spray Revenue (2021-2026)
- 3.2 Global Top Players by Hemostatic Powder Spray Sales (2021-2026)
- 3.3 Global Top Players by Hemostatic Powder Spray Price (2021-2026)
- 3.4 Global Hemostatic Powder Spray Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hemostatic Powder Spray Major Company Production Sites & Headquarters
- 3.6 Global Hemostatic Powder Spray Company, Product Type & Application
- 3.7 Global Hemostatic Powder Spray Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hemostatic Powder Spray Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hemostatic Powder Spray Players Market Share by Revenue in 2025
- 3.8.3 2025 Hemostatic Powder Spray Tier 1, Tier 2, and Tier 3
4 Hemostatic Powder Spray Regional Status and Outlook
- 4.1 Global Hemostatic Powder Spray Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Hemostatic Powder Spray Historic Market Size by Region
- 4.2.1 Global Hemostatic Powder Spray Sales in Volume by Region (2021-2026)
- 4.2.2 Global Hemostatic Powder Spray Sales in Value by Region (2021-2026)
- 4.2.3 Global Hemostatic Powder Spray Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Hemostatic Powder Spray Forecasted Market Size by Region
- 4.3.1 Global Hemostatic Powder Spray Sales in Volume by Region (2027-2032)
- 4.3.2 Global Hemostatic Powder Spray Sales in Value by Region (2027-2032)
- 4.3.3 Global Hemostatic Powder Spray Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hemostatic Powder Spray by Application
- 5.1 Hemostatic Powder Spray Market by Application
- 5.1.1 Hospital Pharmacy
- 5.1.2 Retail Pharmacy
- 5.1.3 Others
- 5.2 Global Hemostatic Powder Spray Market Size by Application
- 5.2.1 Global Hemostatic Powder Spray Market Size Overview by Application (2021-2032)
- 5.2.2 Global Hemostatic Powder Spray Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Hemostatic Powder Spray Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Hemostatic Powder Spray Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Hemostatic Powder Spray Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Hemostatic Powder Spray Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Hemostatic Powder Spray Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Hemostatic Powder Spray Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Medtronic
- 6.1.1 Medtronic Company Information
- 6.1.2 Medtronic Business Overview
- 6.1.3 Medtronic Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Medtronic Hemostatic Powder Spray Product Portfolio
- 6.1.5 Medtronic Recent Developments
- 6.2 QuikClot
- 6.2.1 QuikClot Company Information
- 6.2.2 QuikClot Business Overview
- 6.2.3 QuikClot Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 QuikClot Hemostatic Powder Spray Product Portfolio
- 6.2.5 QuikClot Recent Developments
- 6.3 Pfizer Inc.
- 6.3.1 Pfizer Inc. Company Information
- 6.3.2 Pfizer Inc. Business Overview
- 6.3.3 Pfizer Inc. Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Pfizer Inc. Hemostatic Powder Spray Product Portfolio
- 6.3.5 Pfizer Inc. Recent Developments
- 6.4 Hemostasis, LLC
- 6.4.1 Hemostasis, LLC Company Information
- 6.4.2 Hemostasis, LLC Business Overview
- 6.4.3 Hemostasis, LLC Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Hemostasis, LLC Hemostatic Powder Spray Product Portfolio
- 6.4.5 Hemostasis, LLC Recent Developments
- 6.5 Ethicon Inc.
- 6.5.1 Ethicon Inc. Company Information
- 6.5.2 Ethicon Inc. Business Overview
- 6.5.3 Ethicon Inc. Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Ethicon Inc. Hemostatic Powder Spray Product Portfolio
- 6.5.5 Ethicon Inc. Recent Developments
- 6.6 EndoClot Plus, Inc
- 6.6.1 EndoClot Plus, Inc Company Information
- 6.6.2 EndoClot Plus, Inc Business Overview
- 6.6.3 EndoClot Plus, Inc Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 EndoClot Plus, Inc Hemostatic Powder Spray Product Portfolio
- 6.6.5 EndoClot Plus, Inc Recent Developments
- 6.7 CryoLife, Inc.
- 6.7.1 CryoLife, Inc. Company Information
- 6.7.2 CryoLife, Inc. Business Overview
- 6.7.3 CryoLife, Inc. Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 CryoLife, Inc. Hemostatic Powder Spray Product Portfolio
- 6.7.5 CryoLife, Inc. Recent Developments
- 6.8 Cook Medical
- 6.8.1 Cook Medical Company Information
- 6.8.2 Cook Medical Business Overview
- 6.8.3 Cook Medical Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Cook Medical Hemostatic Powder Spray Product Portfolio
- 6.8.5 Cook Medical Recent Developments
- 6.9 BD
- 6.9.1 BD Company Information
- 6.9.2 BD Business Overview
- 6.9.3 BD Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 BD Hemostatic Powder Spray Product Portfolio
- 6.9.5 BD Recent Developments
- 6.10 Baxter International Inc.
- 6.10.1 Baxter International Inc. Company Information
- 6.10.2 Baxter International Inc. Business Overview
- 6.10.3 Baxter International Inc. Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Baxter International Inc. Hemostatic Powder Spray Product Portfolio
- 6.10.5 Baxter International Inc. Recent Developments
- 6.11 B. Braun
- 6.11.1 B. Braun Company Information
- 6.11.2 B. Braun Business Overview
- 6.11.3 B. Braun Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 B. Braun Hemostatic Powder Spray Product Portfolio
- 6.11.5 B. Braun Recent Developments
- 6.12 Advanced Medical Solutions Group
- 6.12.1 Advanced Medical Solutions Group Company Information
- 6.12.2 Advanced Medical Solutions Group Business Overview
- 6.12.3 Advanced Medical Solutions Group Hemostatic Powder Spray Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Advanced Medical Solutions Group Hemostatic Powder Spray Product Portfolio
- 6.12.5 Advanced Medical Solutions Group Recent Developments
7 North America by Country
- 7.1 North America Hemostatic Powder Spray Sales by Country
- 7.1.1 North America Hemostatic Powder Spray Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Hemostatic Powder Spray Sales by Country (2021-2026)
- 7.1.3 North America Hemostatic Powder Spray Sales Forecast by Country (2027-2032)
- 7.2 North America Hemostatic Powder Spray Market Size by Country
- 7.2.1 North America Hemostatic Powder Spray Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Hemostatic Powder Spray Market Size by Country (2021-2026)
- 7.2.3 North America Hemostatic Powder Spray Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Hemostatic Powder Spray Sales by Country
- 8.1.1 Europe Hemostatic Powder Spray Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Hemostatic Powder Spray Sales by Country (2021-2026)
- 8.1.3 Europe Hemostatic Powder Spray Sales Forecast by Country (2027-2032)
- 8.2 Europe Hemostatic Powder Spray Market Size by Country
- 8.2.1 Europe Hemostatic Powder Spray Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Hemostatic Powder Spray Market Size by Country (2021-2026)
- 8.2.3 Europe Hemostatic Powder Spray Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Hemostatic Powder Spray Sales by Country
- 9.1.1 Asia-Pacific Hemostatic Powder Spray Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Hemostatic Powder Spray Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Hemostatic Powder Spray Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Hemostatic Powder Spray Market Size by Country
- 9.2.1 Asia-Pacific Hemostatic Powder Spray Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Hemostatic Powder Spray Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Hemostatic Powder Spray Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Hemostatic Powder Spray Sales by Country
- 10.1.1 South America Hemostatic Powder Spray Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Hemostatic Powder Spray Sales by Country (2021-2026)
- 10.1.3 South America Hemostatic Powder Spray Sales Forecast by Country (2027-2032)
- 10.2 South America Hemostatic Powder Spray Market Size by Country
- 10.2.1 South America Hemostatic Powder Spray Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Hemostatic Powder Spray Market Size by Country (2021-2026)
- 10.2.3 South America Hemostatic Powder Spray Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Hemostatic Powder Spray Sales by Country
- 11.1.1 Middle East and Africa Hemostatic Powder Spray Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Hemostatic Powder Spray Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Hemostatic Powder Spray Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Hemostatic Powder Spray Market Size by Country
- 11.2.1 Middle East and Africa Hemostatic Powder Spray Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Hemostatic Powder Spray Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Hemostatic Powder Spray Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Hemostatic Powder Spray Value Chain Analysis
- 12.1.1 Hemostatic Powder Spray Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Hemostatic Powder Spray Production Mode & Process
- 12.2 Hemostatic Powder Spray Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Hemostatic Powder Spray Distributors
- 12.2.3 Hemostatic Powder Spray Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst